An artificial-intelligence approach created at Carolina could help bring new drugs to patients quicker.
An artificial-intelligence approach created at the University of North Carolina at Chapel Hill Eshelman School of Pharmacy can teach itself to design new drug molecules from scratch and has the potential to dramatically accelerate the design of new drug candidates.
The system is called Reinforcement Learning for Structural Evolution, known as ReLeaSE, and is an algorithm and computer program that comprises two neural networks which can be thought of as a teacher and a student. The teacher knows the syntax and linguistic rules behind the vocabulary of chemical structures for about 1.7 million known biologically active molecules. By working with the teacher, the student learns over time and becomes better at proposing molecules that are likely to be useful as new medicines.
Alexander Tropsha, Olexandr Isayev and Mariya Popova, all of the UNC Eshelman School of Pharmacy, are the creators of ReLeaSE. The University has applied for a patent for the technology, and the team published a proof-of-concept study in the journal Science Advances last week.
“If we compare this process to learning a language, then after the student learns the molecular alphabet and the rules of the language, they can create new ‘words,’ or molecules,” said Tropsha. “If the new molecule is realistic and has the desired effect, the teacher approves. If not, the teacher disapproves, forcing the student to avoid bad molecules and create good ones.”
ReLeaSE is a powerful innovation to virtual screening, the computational method widely used by the pharmaceutical industry to identify viable drug candidates. Virtual screening allows scientists to evaluate existing large chemical libraries, but the method only works for known chemicals. ReLeASE has the unique ability to create and evaluate new molecules.
“A scientist using virtual screening is like a customer ordering in a restaurant. What can be ordered is usually limited by the menu,” said Isayev. “We want to give scientists a grocery store and a personal chef who can create any dish they want.”
The team has used ReLeaSE to generate molecules with properties that they specified, such as desired bioactivity and safety profiles.The team used the ReLeaSE method to design molecules with customized physical properties, such as melting point and solubility in water, and to design new compounds with inhibitory activity against an enzyme that is associated with leukemia.
“The ability of the algorithm to design new, and therefore immediately patentable, chemical entities with specific biological activities and optimal safety profiles should be highly attractive to an industry that is constantly searching for new approaches to shorten the time it takes to bring a new drug candidate to clinical trials,” said Tropsha.
The Latest on: Drug design
via Google News
The Latest on: Drug design
- Developing a Drug to Fight Diabetes and Obesity in Veteranson May 11, 2020 at 2:48 pm
Nearly 25 percent of veterans receiving care at VA medical centers are diagnosed with diabetes, compared to just over 9 percent of the general population. Through a three-year, $3 million grant from ...
- Computer-Aided Drug Discovery: Initiating a Paradigm Shift in Drug Discovery Industry 2020on May 11, 2020 at 2:40 pm
The computer aided drug design CADD is amalgamated with wet lab techniques to clarify the mechanism of drug resistance to search for new antibiotic targets and to design new and original antibiotics ...
- Insights on the Worldwide AI in Drug Discovery Industry (2019 to 2025) - Featuring IBM, Microsoft & Google Among Others - ResearchAndMarkets.comon May 11, 2020 at 5:23 am
The Global AI In Drug Discovery Market is expected to grow at a robust CAGR during the forecast period. The Global AI In Drug Discovery Market is driven by the growing need to shorten the drug ...
- FDA Approval Granted for Simplified Ventilator Design From Particle Physics Communityon May 10, 2020 at 7:49 pm
In a little over a month, a team of physicists and engineers from around the world took a simplified ventilator design from concept all the way through approval by the U.S. Food and Drug ...
- A Much-Hyped COVID-19 Drug Is Almost Identical to a Black-Market Cat Cureon May 8, 2020 at 2:08 pm
When Robin Kintz’s two kittens, Fiona and Henry, contracted a fatal cat disease last year, she began hearing of a black-market drug from China. The use of the drug, known as GS-441524, is based on ...
- Birx to help lead remdesivir distribution effort as hospitals struggle to access drugon May 8, 2020 at 1:59 pm
Dr. Deborah Birx has been tapped to help manage the distribution of remdesivir to hospitals nationwide, the White House said Friday, amid growing frustration among physicians who ...
- Chemistry breakthrough could speed up drug developmenton May 8, 2020 at 7:10 am
Scientists have successfully developed a new technique to reliably grow crystals of organic soluble molecules from nanoscale droplets, unlocking the potential of accelerated new drug development.
- Design and Implementation of Quality Pharmaceutical Systemson May 8, 2020 at 2:44 am
Efficient design and implementation of quality pharmaceutical systems help to meet the expectations of investors, sponsors and regulators.
- OpenMP API Helps to Speed Up the Search for a COVID-19 Drugon May 7, 2020 at 7:13 pm
The Coronavirus Disease 2019 (COVID-19) has become a major threat worldwide due to its highly contagious nature. As of today, we have passed the ...
via Bing News